Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00234689

Enrollment

Unknown

Registered

2005-10-07

Start date

2002-01-31

Completion date

2004-12-31

Last updated

2008-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder

Brief summary

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

Interventions

DRUGNaltrexone

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of OCD * Treatment with SSRI for at least 10 weeks with no response

Exclusion criteria

* Suffering from any medical condition * treatment with opiates * chronic use of drugs * Hepatitis or other liver related diseases * Incapability to sign an informed consent

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026